Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.17078 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.05582 | 45 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.06502 | 45 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.9609 | 44 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.06807 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.17577 | 46 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.15485 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.11121 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.02952 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.07006 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.05457 | 45 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.99659 | 44 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.07274 | 45 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.0605 | 46 |